Ginkgo datapoints, tangible scientific, and inductive bio partner to deploy ai-driven lab-in-the-loop workflows across the biopharma industry

Boston , aug. 20, 2025 /prnewswire/ -- ginkgo bioworks (nyse: dna), which is building the leading platform for cell programming and biosecurity, today announced that its datapoints offering has entered into a new strategic partnership with inductive bio and tangible scientific to make ai-driven lab-in-the-loop drug discovery broadly accessible across the industry. the partnership aims to deliver capabilities that previously required massive platform investments by combining high-throughput experimental workflows, streamlined compound management, and predictive chemistry ai models into a seamless integrated service that could help scientists design better drugs with fewer resources.
DNA Ratings Summary
DNA Quant Ranking